Cargando…
Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that diet...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244588/ https://www.ncbi.nlm.nih.gov/pubmed/32444616 http://dx.doi.org/10.1038/s41467-020-16220-w |
_version_ | 1783537606208782336 |
---|---|
author | Ke, Wenfan Saba, James A. Yao, Cong-Hui Hilzendeger, Michael A. Drangowska-Way, Anna Joshi, Chintan Mony, Vinod K. Benjamin, Shawna B. Zhang, Sisi Locasale, Jason Patti, Gary J. Lewis, Nathan O’Rourke, Eyleen J. |
author_facet | Ke, Wenfan Saba, James A. Yao, Cong-Hui Hilzendeger, Michael A. Drangowska-Way, Anna Joshi, Chintan Mony, Vinod K. Benjamin, Shawna B. Zhang, Sisi Locasale, Jason Patti, Gary J. Lewis, Nathan O’Rourke, Eyleen J. |
author_sort | Ke, Wenfan |
collection | PubMed |
description | The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that dietary thymidine and serine enhance 5-fluoro 2′deoxyuridine (FUdR) toxicity in C. elegans through different microbial mechanisms. Thymidine promotes microbial conversion of the prodrug FUdR into toxic 5-fluorouridine-5′-monophosphate (FUMP), leading to enhanced host death associated with mitochondrial RNA and DNA depletion, and lethal activation of autophagy. By contrast, serine does not alter FUdR metabolism. Instead, serine alters E. coli’s 1C-metabolism, reduces the provision of nucleotides to the host, and exacerbates DNA toxicity and host death without mitochondrial RNA or DNA depletion; moreover, autophagy promotes survival in this condition. This work implies that diet-microbe interactions can alter the host response to drugs without altering the drug or the host. |
format | Online Article Text |
id | pubmed-7244588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72445882020-06-03 Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion Ke, Wenfan Saba, James A. Yao, Cong-Hui Hilzendeger, Michael A. Drangowska-Way, Anna Joshi, Chintan Mony, Vinod K. Benjamin, Shawna B. Zhang, Sisi Locasale, Jason Patti, Gary J. Lewis, Nathan O’Rourke, Eyleen J. Nat Commun Article The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that dietary thymidine and serine enhance 5-fluoro 2′deoxyuridine (FUdR) toxicity in C. elegans through different microbial mechanisms. Thymidine promotes microbial conversion of the prodrug FUdR into toxic 5-fluorouridine-5′-monophosphate (FUMP), leading to enhanced host death associated with mitochondrial RNA and DNA depletion, and lethal activation of autophagy. By contrast, serine does not alter FUdR metabolism. Instead, serine alters E. coli’s 1C-metabolism, reduces the provision of nucleotides to the host, and exacerbates DNA toxicity and host death without mitochondrial RNA or DNA depletion; moreover, autophagy promotes survival in this condition. This work implies that diet-microbe interactions can alter the host response to drugs without altering the drug or the host. Nature Publishing Group UK 2020-05-22 /pmc/articles/PMC7244588/ /pubmed/32444616 http://dx.doi.org/10.1038/s41467-020-16220-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ke, Wenfan Saba, James A. Yao, Cong-Hui Hilzendeger, Michael A. Drangowska-Way, Anna Joshi, Chintan Mony, Vinod K. Benjamin, Shawna B. Zhang, Sisi Locasale, Jason Patti, Gary J. Lewis, Nathan O’Rourke, Eyleen J. Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
title | Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
title_full | Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
title_fullStr | Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
title_full_unstemmed | Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
title_short | Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
title_sort | dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244588/ https://www.ncbi.nlm.nih.gov/pubmed/32444616 http://dx.doi.org/10.1038/s41467-020-16220-w |
work_keys_str_mv | AT kewenfan dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT sabajamesa dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT yaoconghui dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT hilzendegermichaela dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT drangowskawayanna dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT joshichintan dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT monyvinodk dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT benjaminshawnab dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT zhangsisi dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT locasalejason dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT pattigaryj dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT lewisnathan dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion AT orourkeeyleenj dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion |